X
Record #53946

Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial

Original paper date
Jul 12, 2022
Institution
Neurology and Psychiatry Department, Shebin Elkom Teaching Hospital, Menoufia University, Shebin Elkom, Egypt · Department of Biostatistics, High Institute of Public Health, Alexandria University, Alexandria, Egypt · Clinical Pharmacology Department, Faculty of Medicine, Menoufia University, Shebin Elkom, Egypt · Gastrohepatology and Endemic Medicine Department, Shebin Elkom Teaching Hospital, Menoufia University, Shebin Elkom, Egypt · Gastrohepatology and Endemic Medicine Department, Ahmed Maher Teaching Hospital, Cairo, Egypt · General Surgery Department, Shebin Elkom Teaching Hospital, Menoufia University, Shebin Elkom, Egypt · Department of Biochemistry, Faculty of Pharmacy, Menoufia University, Shebin El-Kom, Egypt · Clinical Pharmacy Department, Faculty of Pharmacy, University of Sadat City (USC), Sadat City, Egypt
Open access
No
Article type
Clinical Study
Broad categories
(HSC) Medicine - Infectious Disease(HSC) Medicine - Pharmacology
Citation lifecycle

How this paper is being cited

Pre-retraction
1
Same day
0
Post-retraction
1
% post-retraction
50.0%
~0.5 citations/yr before retraction · ~0.4 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse